PerkinElmer has agreed to buy Oxford Immunotec for $591m to add the UK company’s T cell immunology expertise and proprietary tuberculosis testing technology to its line of infectious disease testing products.
“Oxford Immunotec’s highly sensitive test and their team’s passion for solving complex health issues make it a natural fit with...